Vagus nerve stimulation devices peddle unproven cures as market booms

Regulatory authority fragmentation between national health agencies (FDA, ANVISA, EMA) weakens enforcement capacity. Tech platforms and influencer networks operate across borders with minimal oversight, shifting power from traditional medical institutions to decentralized digital marketers.

Similar to early 20th-century patent medicine era before FDA establishment; reflects ongoing tension between innovation speed and regulatory capacity in digital health markets.

Consumers face significant financial losses purchasing ineffective devices at premium prices, potential health risks from unproven treatments, and opportunity costs from delaying legitimate medical care. Trust in wellness products and digital health recommendations may erode.

Regulatory agencies (FDA, ANVISA) likely to increase enforcement against unsubstantiated medical claims, implement stricter pre-market approval requirements for consumer neurostimulation devices, and potentially regulate influencer health endorsements. May require social media platforms to remove misleading health content.